| S.No: |
Product |
Title of the patent |
| 1 |
Fexofenadine Intermediate |
Process patent |
| 2 |
Fluvastatin sodium |
Novel Process Fluvastatin intermediate |
| 3 |
Pitavastatin calcium |
Novel process Pitavastatin and its intermediate |
| 4 |
Rosuvastatin calcium |
Novel process for Rosuvastatin |
| 5 |
Alfuzosin HCl |
Improved process for Alfuzosin hydchloride and its polymophs |
| 6 |
Fluvastatin racemic |
Novel process for Fluvastatin and its intermediates |
| 7 |
Pantoprazole sodium |
Improved process for Pantoprazole and its pharmaceutically acceptable salts |
| 8 |
Alfuzosin HCl |
Improved Process |
| 9 |
Clopidogrel HBr |
Improved Process |
| 10 |
Perindopril Erbumine |
Novel crystalline Form |
| 11 |
Eprosartan |
Improved Process |
| 12 |
Fluvastatin sodium |
Industrial Process |
| 13 |
Olmesartan medoxomil |
Improved Process |
| 14 |
Atorvastatin |
Novel process for amorphous form |
| 15 |
Tramiprosate |
Improved process for tramiprosate and its novel polymorph |
| 16 |
Duloxetine(Provisional) |
Novel process |
| 17 |
Carbinoxamine |
Improved process for carbinoxamine and its novel polymorph |
| 18 |
Olmesartan medoxomil |
INovel process |
| 19 |
Gemifloxacin |
Novel polymorph |
| 20 |
Telmisartan |
Novel process |
| 21 |
Prasugrel |
Improved process for prasugrel and its pharmaceutically acceptable salts thereof |
| 22 |
Ranolazine |
Improved Process for Pure Ranolazine and Its Pharmaceutically acceptable Salts |
| 23 |
Clopidogrel besylate |
Novel process |
| 24 |
Bosentan (Provisonal) |
Novel process |
| 25 |
Thiophene-2-ethylamine salt of API |
Novel amine salts |
| 26 |
Darifenacin |
Novel and Improved Processes for Intermediates, Darifenacin, and Its Pharmaceutically Acceptable Salts |
| 27 |
Darusentan |
Improved Process |
| 28 |
Ambrisentan |
Improved Process |
| 29 |
Nebivolol |
Improved Process |
| 30 |
Pitavastatin calcium |
Improved process for the highly pure pitavastatin and its pharmaceutically acceptable salts |
| 31 |
Dexlansoprazole |
Novel process |
| 32 |
Ambrisentan |
Improved process for ambrisentan and its novel amine salts |
| 33 |
Almotriptan |
Improved process for almotriptan and its pharmaceutically acceptable salts |
| 34 |
Sitagliptin (provisional) |
Novel process for sitagliptin and its pharmaceutically acceptable salts |
| 35 |
Pramipexole |
Improved process for pramipexole and its pharmaceutically accetable salts |
| 36 |
Trospium chloride |
Improved Process |
| 37 |
Bosentan |
Improved Process |
| 38 |
Deferasirox |
Process for Deferasirox and its novel amine salts |
| 39 |
Aripiprazole |
Process for anhydrous type I crystals |
| 40 |
Olmesartan |
Novel solvate of trityl olmesartan as well as improved process |
| 41 |
Oseltamivir |
Novel salts of ethyl (3R, 4S, %R)-4,5-imino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate |
